1. Home
  2. TGS vs SHC Comparison

TGS vs SHC Comparison

Compare TGS & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transportadora de Gas del Sur SA TGS

TGS

Transportadora de Gas del Sur SA TGS

HOLD

Current Price

$31.43

Market Cap

4.7B

Sector

Utilities

ML Signal

HOLD

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.86

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGS
SHC
Founded
1992
2015
Country
Argentina
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.4B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
TGS
SHC
Price
$31.43
$15.86
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$40.00
$20.33
AVG Volume (30 Days)
388.4K
2.6M
Earning Date
05-08-2026
05-01-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
68.75
EPS
N/A
0.27
Revenue
N/A
$1,163,617,000.00
Revenue This Year
$2.13
$7.51
Revenue Next Year
N/A
$6.00
P/E Ratio
$17.56
$59.41
Revenue Growth
N/A
5.74
52 Week Low
$19.74
$10.17
52 Week High
$36.35
$19.85

Technical Indicators

Market Signals
Indicator
TGS
SHC
Relative Strength Index (RSI) 42.28 59.71
Support Level $28.08 $15.19
Resistance Level $33.60 $16.55
Average True Range (ATR) 1.46 0.42
MACD -0.48 0.27
Stochastic Oscillator 16.89 84.85

Price Performance

Historical Comparison
TGS
SHC

About TGS Transportadora de Gas del Sur SA TGS

Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Share on Social Networks: